R-CHOP in the treatment of DLBCL: Single institution experience from north India.

被引：0
|
作者：
Vaid, AK [1 ]
Gupta, S [1 ]
Doval, DC [1 ]
Talwar, V [1 ]
Gupta, R [1 ]
Sharma, JB [1 ]
Chaturvedi, AK [1 ]
Prakesh, N [1 ]
机构：
[1] Rajiv Gandhi Canc Inst & Res Ctr, Delhi, India
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.4773.4773
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4773
引用
收藏
页码：273B / 273B
页数：1
相关论文
共 50 条
  • [41] R-GCVP As Second Line Treatment in Elderly Patients with DLBCL Who Fail R-CHOP and Are Not Candidates for Intensive Therapy
    Gration, B.
    Duran, A.
    Mir, N.
    Yuen, L.
    Warner, M.
    Stanley, K.
    Brady, J.
    Mikhaeel, G.
    Fields, P.
    Wrench, D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 172 - 172
  • [42] ASSOCIATION OF POLYMORPHISM RS1625895 GENE TP53 WITH EFFECTIVENESS OF R-CHOP TREATMENT OF DLBCL
    Voropaeva, E.
    Pospelova, T.
    Voevoda, M.
    Maximov, V.
    Berezina, O.
    HAEMATOLOGICA, 2014, 99 : 697 - 697
  • [43] R-GCVP As Second Line Treatment in Elderly Patients with DLBCL Who Fail R-CHOP and Are Not Candidates for Intensive Therapy
    Gration, Betty
    Duran, Ana
    Mir, Naheed
    Yuen, Lisa
    Warner, Marcus
    Stanley, Karen
    Brady, Jessica
    Mikhaeel, George
    Fields, Paul A.
    Wrench, David
    BLOOD, 2017, 130
  • [44] CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies
    Ayed O. Ayed
    Annalisa Chiappella
    Levi Pederson
    Betsy R. Laplant
    Angela Giovanna Congiu
    Gianluca Gaidano
    Michele Spina
    Alessandro Re
    Federica Cavallo
    Gerardo Musuraca
    William R. Macon
    Thomas Witzig
    Umberto Vitolo
    Grzegorz S. Nowakowski
    Blood Cancer Journal, 8
  • [45] CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies
    Ayed, Ayed O.
    Chiappella, Annalisa
    Pederson, Levi
    Laplant, Betsy R.
    Congiu, Angela Giovanna
    Gaidano, Gianluca
    Spina, Michele
    Re, Alessandro
    Cavallo, Federica
    Musuraca, Gerardo
    Macon, William R.
    Witzig, Thomas
    Vitolo, Umberto
    Nowakowski, Grzegorz S.
    BLOOD CANCER JOURNAL, 2018, 8
  • [46] Phase III Trial of Subcutaneous Epcoritamab plus R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2
    Sehn, Laurie
    Chamuleau, Martine
    Lenz, Georg
    Clausen, Michael
    Haioun, Corinne
    Izutsu, Koji
    Davies, Andrew
    Zhu, Jun
    Oki, Toshiko
    Szafer-Glusman, Edith
    Conlon, Rebekah
    Chiou, Hueiyu
    Ipe, David
    Elliott, Brian
    Wu, Jun
    Salles, Gilles
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S440 - S440
  • [47] Phase 3 trial of subcutaneous epcoritamab plus R-CHOP versus R-CHOP in patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL): EPCORE DLBCL-2.
    Sehn, Laurie Helen
    Chamuleau, Martine
    Lenz, Georg
    Clausen, Michael
    Haioun, Corinne
    Izutsu, Koji
    Davies, Andrew John John
    Zhu, Jun
    Oki, Toshiko
    Szafer-Glusman, Edith
    Conlon, Rebekah
    Chiou, Hueiyu
    Ipe, David
    Elliott, Brian
    Wu, Jun
    Salles, Gilles A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] A Matched Comparison of Pola-R-CHP Vs. R-CHOP for DLBCL with Extranodal Involvement
    Yang, Shenmiao
    Wei, Rong
    Liu, Yang
    Dou, Xuelin
    Wen, Lei
    Lu, Jin
    Wang, Fengrong
    Mo, Xiaodong
    Huang, Xiaojun
    BLOOD, 2024, 144 : 6478 - 6479
  • [49] Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study
    Winter, Jane N.
    Weller, Edie A.
    Horning, Sandra J.
    Krajewska, Maryla
    Variakojis, Daina
    Habermann, Thomas M.
    Fisher, Richard I.
    Kurtin, Paul J.
    Macon, William R.
    Chhanabhai, Mukesh
    Felgar, Raymond E.
    Hsi, Eric D.
    Medeiros, L. Jeffrey
    Weick, James K.
    Reed, John C.
    Gascoyne, Randy D.
    BLOOD, 2006, 107 (11) : 4207 - 4213
  • [50] CCND2 mRNA Expression Is Correlated With R-CHOP Treatment Efficacy and Prognosis in Patients With ABC-DLBCL
    Wang, Di
    Zhang, Yue
    Che, Yi-Qun
    FRONTIERS IN ONCOLOGY, 2020, 10
12345